BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15090152)

  • 1. A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases.
    Rodems SM; Hamman BD; Lin C; Zhao J; Shah S; Heidary D; Makings L; Stack JH; Pollok BA
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):9-19. PubMed ID: 15090152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
    Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
    J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors.
    Johnston PA; Foster CA; Shun TY; Skoko JJ; Shinde S; Wipf P; Lazo JS
    Assay Drug Dev Technol; 2007 Jun; 5(3):319-32. PubMed ID: 17638532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
    Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
    J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of protein kinases and phosphatases in signal transduction.
    Hardie DG
    Symp Soc Exp Biol; 1990; 44():241-55. PubMed ID: 1966636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinases and phosphatases are involved in erythropoietin-mediated signal transduction.
    Spivak JL; Fisher J; Isaacs MA; Hankins WD
    Exp Hematol; 1992 May; 20(4):500-4. PubMed ID: 1314737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases.
    Gaudet EA; Huang KS; Zhang Y; Huang W; Mark D; Sportsman JR
    J Biomol Screen; 2003 Apr; 8(2):164-75. PubMed ID: 12844437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
    Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
    J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery.
    Sawyer TK; Shakespeare WC; Wang Y; Sundaramoorthi R; Huang WS; Metcalf CA; Thomas M; Lawrence BM; Rozamus L; Noehre J; Zhu X; Narula S; Bohacek RS; Weigele M; Dalgarno DC
    Med Chem; 2005 May; 1(3):293-319. PubMed ID: 16787325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A homogeneous, nonradioactive high-throughput fluorogenic protein phosphatase assay.
    Kupcho K; Hsiao K; Bulleit B; Goueli SA
    J Biomol Screen; 2004 Apr; 9(3):223-31. PubMed ID: 15140384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput kinase assays with protein substrates using fluorescent polymer superquenching.
    Rininsland F; Stankewicz C; Weatherford W; McBranch D
    BMC Biotechnol; 2005 May; 5():16. PubMed ID: 15927069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of the catalytic subunit of protein phosphatase 1 from Neurospora crassa.
    Szöór B; Dombrádi V; Gergely P; Fehér Z
    Acta Biol Hung; 1997; 48(3):289-302. PubMed ID: 9406609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase 2A is involved in the regulation of protein kinase A signaling pathway during in vitro chondrogenesis.
    Zákány R; Szucs K; Bakó E; Felszeghy S; Czifra G; Bíró T; Módis L; Gergely P
    Exp Cell Res; 2002 Apr; 275(1):1-8. PubMed ID: 11925100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways of signaling in nonspecific cytotoxic cells: effects of protein kinase and phosphatase inhibitors and evidence for membrane tyrosine phosphorylation.
    Jaso-Friedmann L; Leary JH; Evans DL
    Cell Immunol; 1994 Jan; 153(1):142-53. PubMed ID: 7506998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A homogeneous, nonradioactive high-throughput fluorogenic protein kinase assay.
    Kupcho K; Somberg R; Bulleit B; Goueli SA
    Anal Biochem; 2003 Jun; 317(2):210-7. PubMed ID: 12758259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of a stable MK2-EGFP cell line and subsequent development of a high-content imaging assay on the Cellomics ArrayScan platform to screen for p38 mitogen-activated protein kinase inhibitors.
    Williams RG; Kandasamy R; Nickischer D; Trask OJ; Laethem C; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():364-89. PubMed ID: 17110203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of a targeted library of protein phosphatase inhibitors.
    Wipf P; Aslan DC; Luci DK; Southwick EC; Lazo JS
    Biotechnol Bioeng; 2000; 71(1):58-70. PubMed ID: 10629537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropin induces mitogen-activated protein kinase phosphatase 1 in Y1 mouse adrenocortical tumor cells.
    Bey P; Gorostizaga AB; Maloberti PM; Lozano RC; Poderoso C; Cornejo Maciel F; Podestá EJ; Paz C
    Endocrinology; 2003 Apr; 144(4):1399-406. PubMed ID: 12639923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors.
    Rokhlin OW; Cohen MB
    Cancer Lett; 1995 Nov; 98(1):103-10. PubMed ID: 8529197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.